The biomanufacturing sector is poised for major growth and China is a rising star in the global biomanufacturing market. Made in China 2025 industry plan underlines perks and massive expansion plan; USD $300 billion investments nationwide by 2020 and paves ways to be more innovative and competitive globally and improving quality standards. China’s biomanufacturing sector is a hotbed for investments, pharma giants’ top destination to expand their manufacturing capacities footprint in China and indigenous firms establishing manufacturing might not only locally but also going global.
The 10th Annual Biomanufacturing Conference returns to Shanghai on 8 – 9 July 2020 to spotlight on manufacturing trends, technologies, new facilities expansion, tech transfer, and investments. The event brings together local and international biotherapeutic developers and contract manufacturing organizations to discuss and debate on the biomanufacturing landscape of the biotech industry in China.
This event is part of Biopharma Development Week and is co-located with the 11th Annual Biosimilars Asia and 9th Annual Cell Line Development & Engineering Asia conferences.
- 2 Day Conference: CNY 7,000
- Gala Dinner: CNY 350
- Start Up Rate: CNY 2,450